Thus, the purpose of the current study was to detect the role of the NF-κB signaling pathway on growth and apoptosis of CCA cells, in vitro, in vivo and ex vivo, using DHMEQ, an effective NF-κB inhibitor. This evidence concerns the gene NFKB1 and cholangiocarcinoma.